Characterization of dose-FEV1 response of tralokinumab, an investigational anti-IL13 monoclonal antibody in patients with uncontrolled asthma : a population pharmacokinetic/pharmacodynamic modeling analysis
作者： B. Agoram , R. Kantaria , P. Baverel , Mats Karlsson
DOI: 10.1111/ALL.12715
关键词: Immunology 、 In patient 、 Medicine 、 Uncontrolled asthma 、 Pharmacology 、 Pharmacodynamics 、 Tralokinumab 、 Pharmacokinetics 、 Population 、 Pharmacokinetic pharmacodynamic 、 Monoclonal antibody
摘要: Characterization of dose-FEV1 response tralokinumab, an investigational anti-IL13 monoclonal antibody in patients with uncontrolled asthma : a population pharmacokinetic/pharmacodynamic modeling analysis
sci-hub.st 参考文章(0)